Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents

Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents

US Patent 12312353 · Granted May 27, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Quinoline compounds and compositions for inhibiting EZH22025
FGFR inhibitor, preparation method therefor and application thereof2025
Contact connector and electronic device2025
Mouse2024
CD73 inhibitor, preparation method therefor and application thereof2024
FGFR4 inhibitor, preparation method therefor and pharmaceutical use thereof2023
Semiconductor device and method for manufacturing the same2022
Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents2022
Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents2022
Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents2022
Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents2022
Piperidinyl-methyl-purineamines as NSD2 inhibitors and anti-cancer agents2022